nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP3A5—Sulfasalazine—Crohn's disease	0.0814	0.404	CbGbCtD
Cyclophosphamide—CYP2C19—Prednisone—Crohn's disease	0.0525	0.26	CbGbCtD
Cyclophosphamide—ABCB1—Prednisone—Crohn's disease	0.0424	0.21	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisone—Crohn's disease	0.0254	0.126	CbGbCtD
Cyclophosphamide—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00659	0.00826	CcSEcCtD
Cyclophosphamide—Bacterial infection—Azathioprine—Crohn's disease	0.00657	0.00823	CcSEcCtD
Cyclophosphamide—Myelosuppression—Azathioprine—Crohn's disease	0.00647	0.0081	CcSEcCtD
Cyclophosphamide—Growth retardation—Prednisone—Crohn's disease	0.00644	0.00807	CcSEcCtD
Cyclophosphamide—Water retention—Prednisone—Crohn's disease	0.00644	0.00807	CcSEcCtD
Cyclophosphamide—Pericarditis—Mesalazine—Crohn's disease	0.00639	0.008	CcSEcCtD
Cyclophosphamide—Interstitial pneumonia—Azathioprine—Crohn's disease	0.00628	0.00786	CcSEcCtD
Cyclophosphamide—Telangiectasia—Prednisone—Crohn's disease	0.0062	0.00777	CcSEcCtD
Cyclophosphamide—Prurigo—Mesalazine—Crohn's disease	0.00598	0.0075	CcSEcCtD
Cyclophosphamide—Pancreatitis acute—Mesalazine—Crohn's disease	0.00598	0.0075	CcSEcCtD
Cyclophosphamide—Interstitial pneumonia—Mesalazine—Crohn's disease	0.00572	0.00716	CcSEcCtD
Cyclophosphamide—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00549	0.00687	CcSEcCtD
Cyclophosphamide—Ulcer—Mercaptopurine—Crohn's disease	0.00538	0.00674	CcSEcCtD
Cyclophosphamide—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00518	0.00649	CcSEcCtD
Cyclophosphamide—Systemic lupus erythematosus—Mesalazine—Crohn's disease	0.00499	0.00625	CcSEcCtD
Cyclophosphamide—Nephropathy toxic—Mesalazine—Crohn's disease	0.00481	0.00603	CcSEcCtD
Cyclophosphamide—Blood lactate dehydrogenase increased—Mesalazine—Crohn's disease	0.00475	0.00595	CcSEcCtD
Cyclophosphamide—Platelet count decreased—Mesalazine—Crohn's disease	0.00464	0.00582	CcSEcCtD
Cyclophosphamide—Neoplasm—Mercaptopurine—Crohn's disease	0.0046	0.00577	CcSEcCtD
Cyclophosphamide—Mouth ulceration—Mercaptopurine—Crohn's disease	0.0046	0.00577	CcSEcCtD
Cyclophosphamide—Thromboembolism—Prednisone—Crohn's disease	0.0046	0.00576	CcSEcCtD
Cyclophosphamide—Sepsis—Mercaptopurine—Crohn's disease	0.00442	0.00553	CcSEcCtD
Cyclophosphamide—Pigmentation disorder—Prednisone—Crohn's disease	0.00438	0.00549	CcSEcCtD
Cyclophosphamide—Interstitial lung disease—Azathioprine—Crohn's disease	0.00429	0.00537	CcSEcCtD
Cyclophosphamide—Nail disorder—Mesalazine—Crohn's disease	0.00426	0.00534	CcSEcCtD
Cyclophosphamide—Parosmia—Mesalazine—Crohn's disease	0.00426	0.00534	CcSEcCtD
Cyclophosphamide—Herpes zoster—Azathioprine—Crohn's disease	0.00403	0.00505	CcSEcCtD
Cyclophosphamide—Cholestasis—Azathioprine—Crohn's disease	0.00399	0.005	CcSEcCtD
Cyclophosphamide—Hepatotoxicity—Azathioprine—Crohn's disease	0.00393	0.00492	CcSEcCtD
Cyclophosphamide—Interstitial lung disease—Mesalazine—Crohn's disease	0.0039	0.00489	CcSEcCtD
Cyclophosphamide—Thrombosis—Mesalazine—Crohn's disease	0.0039	0.00489	CcSEcCtD
Cyclophosphamide—Blister—Mesalazine—Crohn's disease	0.00383	0.0048	CcSEcCtD
Cyclophosphamide—Menorrhagia—Mesalazine—Crohn's disease	0.00373	0.00468	CcSEcCtD
Cyclophosphamide—Cholestasis—Mesalazine—Crohn's disease	0.00364	0.00456	CcSEcCtD
Cyclophosphamide—Pleural effusion—Mesalazine—Crohn's disease	0.00361	0.00452	CcSEcCtD
Cyclophosphamide—Hepatotoxicity—Mesalazine—Crohn's disease	0.00358	0.00448	CcSEcCtD
Cyclophosphamide—Neoplasm malignant—Azathioprine—Crohn's disease	0.00355	0.00445	CcSEcCtD
Cyclophosphamide—Rhinorrhoea—Mesalazine—Crohn's disease	0.00341	0.00427	CcSEcCtD
Cyclophosphamide—Impaired healing—Prednisone—Crohn's disease	0.00338	0.00423	CcSEcCtD
Cyclophosphamide—Tenderness—Mesalazine—Crohn's disease	0.00317	0.00397	CcSEcCtD
Cyclophosphamide—Pancreatitis acute—Prednisone—Crohn's disease	0.00317	0.00397	CcSEcCtD
Cyclophosphamide—Amenorrhoea—Mesalazine—Crohn's disease	0.00314	0.00394	CcSEcCtD
Cyclophosphamide—Vasculitis—Azathioprine—Crohn's disease	0.00311	0.00389	CcSEcCtD
Cyclophosphamide—Oropharyngeal pain—Mesalazine—Crohn's disease	0.00304	0.00381	CcSEcCtD
Cyclophosphamide—Pancytopenia—Mercaptopurine—Crohn's disease	0.00303	0.0038	CcSEcCtD
Cyclophosphamide—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00292	0.00366	CcSEcCtD
Cyclophosphamide—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.00292	0.00366	CcSEcCtD
Cyclophosphamide—Colitis—Azathioprine—Crohn's disease	0.00291	0.00365	CcSEcCtD
Cyclophosphamide—Embolism venous—Prednisone—Crohn's disease	0.0029	0.00363	CcSEcCtD
Cyclophosphamide—Stomatitis—Mercaptopurine—Crohn's disease	0.00278	0.00348	CcSEcCtD
Cyclophosphamide—Neoplasm—Azathioprine—Crohn's disease	0.00274	0.00344	CcSEcCtD
Cyclophosphamide—Cystitis noninfective—Mesalazine—Crohn's disease	0.0027	0.00338	CcSEcCtD
Cyclophosphamide—Influenza like illness—Mesalazine—Crohn's disease	0.00268	0.00336	CcSEcCtD
Cyclophosphamide—Cystitis—Mesalazine—Crohn's disease	0.00267	0.00334	CcSEcCtD
Cyclophosphamide—Colitis—Mesalazine—Crohn's disease	0.00265	0.00332	CcSEcCtD
Cyclophosphamide—Menstruation irregular—Prednisone—Crohn's disease	0.00264	0.00331	CcSEcCtD
Cyclophosphamide—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00252	0.00316	CcSEcCtD
Cyclophosphamide—Bladder pain—Mesalazine—Crohn's disease	0.0025	0.00313	CcSEcCtD
Cyclophosphamide—Mouth ulceration—Mesalazine—Crohn's disease	0.0025	0.00313	CcSEcCtD
Cyclophosphamide—Hepatic failure—Azathioprine—Crohn's disease	0.00245	0.00307	CcSEcCtD
Cyclophosphamide—Febrile neutropenia—Prednisone—Crohn's disease	0.00243	0.00304	CcSEcCtD
Cyclophosphamide—Embolism—Prednisone—Crohn's disease	0.00228	0.00285	CcSEcCtD
Cyclophosphamide—Gastroenteritis—Mesalazine—Crohn's disease	0.00226	0.00283	CcSEcCtD
Cyclophosphamide—Alopecia—Mercaptopurine—Crohn's disease	0.00226	0.00283	CcSEcCtD
Cyclophosphamide—Deafness—Mesalazine—Crohn's disease	0.00224	0.00281	CcSEcCtD
Cyclophosphamide—Hepatic failure—Mesalazine—Crohn's disease	0.00223	0.0028	CcSEcCtD
Cyclophosphamide—Renal failure acute—Mesalazine—Crohn's disease	0.00217	0.00272	CcSEcCtD
Cyclophosphamide—Atrial fibrillation—Mesalazine—Crohn's disease	0.00212	0.00265	CcSEcCtD
Cyclophosphamide—Renal impairment—Mesalazine—Crohn's disease	0.00211	0.00264	CcSEcCtD
Cyclophosphamide—Dermatitis bullous—Mesalazine—Crohn's disease	0.0021	0.00263	CcSEcCtD
Cyclophosphamide—Hepatomegaly—Prednisone—Crohn's disease	0.00207	0.00259	CcSEcCtD
Cyclophosphamide—Anaemia—Mercaptopurine—Crohn's disease	0.00206	0.00258	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00201	0.00251	CcSEcCtD
Cyclophosphamide—Leukopenia—Mercaptopurine—Crohn's disease	0.00199	0.0025	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00198	0.00248	CcSEcCtD
Cyclophosphamide—Arthralgia—Mercaptopurine—Crohn's disease	0.00189	0.00237	CcSEcCtD
Cyclophosphamide—Necrosis—Prednisone—Crohn's disease	0.00186	0.00233	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Azathioprine—Crohn's disease	0.00182	0.00229	CcSEcCtD
Cyclophosphamide—Oedema—Mercaptopurine—Crohn's disease	0.00182	0.00228	CcSEcCtD
Cyclophosphamide—Pancytopenia—Azathioprine—Crohn's disease	0.00181	0.00226	CcSEcCtD
Cyclophosphamide—Nasopharyngitis—Mesalazine—Crohn's disease	0.00179	0.00225	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00178	0.00223	CcSEcCtD
Cyclophosphamide—Anorexia—Mercaptopurine—Crohn's disease	0.00173	0.00217	CcSEcCtD
Cyclophosphamide—Pneumonia—Azathioprine—Crohn's disease	0.00171	0.00214	CcSEcCtD
Cyclophosphamide—Bronchospasm—Mesalazine—Crohn's disease	0.0017	0.00214	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00168	0.00211	CcSEcCtD
Cyclophosphamide—Amenorrhoea—Prednisone—Crohn's disease	0.00166	0.00208	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Mesalazine—Crohn's disease	0.00166	0.00208	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00165	0.00207	CcSEcCtD
Cyclophosphamide—Pancytopenia—Mesalazine—Crohn's disease	0.00165	0.00206	CcSEcCtD
Cyclophosphamide—Viral infection—Prednisone—Crohn's disease	0.00162	0.00203	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Azathioprine—Crohn's disease	0.00158	0.00198	CcSEcCtD
Cyclophosphamide—Decreased appetite—Mercaptopurine—Crohn's disease	0.00158	0.00198	CcSEcCtD
Cyclophosphamide—Weight increased—Mesalazine—Crohn's disease	0.00158	0.00198	CcSEcCtD
Cyclophosphamide—Pneumonia—Mesalazine—Crohn's disease	0.00155	0.00195	CcSEcCtD
Cyclophosphamide—Ulcer—Prednisone—Crohn's disease	0.00155	0.00194	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00153	0.00192	CcSEcCtD
Cyclophosphamide—Haemoglobin—Azathioprine—Crohn's disease	0.00153	0.00192	CcSEcCtD
Cyclophosphamide—Haemorrhage—Azathioprine—Crohn's disease	0.00152	0.00191	CcSEcCtD
Cyclophosphamide—Renal failure—Mesalazine—Crohn's disease	0.00152	0.0019	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00151	0.0019	CcSEcCtD
Cyclophosphamide—Stomatitis—Mesalazine—Crohn's disease	0.00151	0.00189	CcSEcCtD
Cyclophosphamide—Jaundice—Mesalazine—Crohn's disease	0.00151	0.00189	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Mesalazine—Crohn's disease	0.0015	0.00188	CcSEcCtD
Cyclophosphamide—Vasculitis—Prednisone—Crohn's disease	0.0015	0.00188	CcSEcCtD
Cyclophosphamide—Sweating—Mesalazine—Crohn's disease	0.00148	0.00186	CcSEcCtD
Cyclophosphamide—Haematuria—Mesalazine—Crohn's disease	0.00147	0.00185	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Mesalazine—Crohn's disease	0.00144	0.00181	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Azathioprine—Crohn's disease	0.00144	0.0018	CcSEcCtD
Cyclophosphamide—Body temperature increased—Mercaptopurine—Crohn's disease	0.00144	0.0018	CcSEcCtD
Cyclophosphamide—Haemoglobin—Mesalazine—Crohn's disease	0.00139	0.00175	CcSEcCtD
Cyclophosphamide—Rhinitis—Mesalazine—Crohn's disease	0.00139	0.00174	CcSEcCtD
Cyclophosphamide—Fluid retention—Prednisone—Crohn's disease	0.00139	0.00174	CcSEcCtD
Cyclophosphamide—Haemorrhage—Mesalazine—Crohn's disease	0.00139	0.00174	CcSEcCtD
Cyclophosphamide—Hepatitis—Mesalazine—Crohn's disease	0.00139	0.00174	CcSEcCtD
Cyclophosphamide—Chills—Azathioprine—Crohn's disease	0.00137	0.00171	CcSEcCtD
Cyclophosphamide—Arrhythmia—Azathioprine—Crohn's disease	0.00136	0.0017	CcSEcCtD
Cyclophosphamide—Alopecia—Azathioprine—Crohn's disease	0.00135	0.00169	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00134	0.00168	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Mesalazine—Crohn's disease	0.00131	0.00164	CcSEcCtD
Cyclophosphamide—Pulmonary oedema—Prednisone—Crohn's disease	0.0013	0.00163	CcSEcCtD
Cyclophosphamide—Tinnitus—Mesalazine—Crohn's disease	0.00129	0.00162	CcSEcCtD
Cyclophosphamide—Sepsis—Prednisone—Crohn's disease	0.00127	0.00159	CcSEcCtD
Cyclophosphamide—Chills—Mesalazine—Crohn's disease	0.00124	0.00156	CcSEcCtD
Cyclophosphamide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00124	0.00156	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Azathioprine—Crohn's disease	0.00123	0.00154	CcSEcCtD
Cyclophosphamide—Alopecia—Mesalazine—Crohn's disease	0.00123	0.00154	CcSEcCtD
Cyclophosphamide—Anaemia—Azathioprine—Crohn's disease	0.00123	0.00154	CcSEcCtD
Cyclophosphamide—Diabetes mellitus—Prednisone—Crohn's disease	0.00122	0.00153	CcSEcCtD
Cyclophosphamide—Erythema—Mesalazine—Crohn's disease	0.00121	0.00151	CcSEcCtD
Cyclophosphamide—Malaise—Azathioprine—Crohn's disease	0.0012	0.0015	CcSEcCtD
Cyclophosphamide—Leukopenia—Azathioprine—Crohn's disease	0.00119	0.00149	CcSEcCtD
Cyclophosphamide—Dysgeusia—Mesalazine—Crohn's disease	0.00118	0.00148	CcSEcCtD
Cyclophosphamide—Cardiac failure congestive—Prednisone—Crohn's disease	0.00117	0.00147	CcSEcCtD
Cyclophosphamide—Muscle spasms—Mesalazine—Crohn's disease	0.00116	0.00145	CcSEcCtD
Cyclophosphamide—Vomiting—Mercaptopurine—Crohn's disease	0.00115	0.00145	CcSEcCtD
Cyclophosphamide—Rash—Mercaptopurine—Crohn's disease	0.00115	0.00143	CcSEcCtD
Cyclophosphamide—Dermatitis—Mercaptopurine—Crohn's disease	0.00114	0.00143	CcSEcCtD
Cyclophosphamide—Vision blurred—Mesalazine—Crohn's disease	0.00114	0.00143	CcSEcCtD
Cyclophosphamide—Tremor—Mesalazine—Crohn's disease	0.00113	0.00142	CcSEcCtD
Cyclophosphamide—Arthralgia—Azathioprine—Crohn's disease	0.00113	0.00141	CcSEcCtD
Cyclophosphamide—Myalgia—Azathioprine—Crohn's disease	0.00113	0.00141	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Mesalazine—Crohn's disease	0.00112	0.0014	CcSEcCtD
Cyclophosphamide—Anaemia—Mesalazine—Crohn's disease	0.00112	0.0014	CcSEcCtD
Cyclophosphamide—Discomfort—Azathioprine—Crohn's disease	0.00112	0.0014	CcSEcCtD
Cyclophosphamide—Malaise—Mesalazine—Crohn's disease	0.00109	0.00136	CcSEcCtD
Cyclophosphamide—Cardiac failure—Prednisone—Crohn's disease	0.00109	0.00136	CcSEcCtD
Cyclophosphamide—Leukopenia—Mesalazine—Crohn's disease	0.00108	0.00135	CcSEcCtD
Cyclophosphamide—Nausea—Mercaptopurine—Crohn's disease	0.00108	0.00135	CcSEcCtD
Cyclophosphamide—Infection—Azathioprine—Crohn's disease	0.00108	0.00135	CcSEcCtD
Cyclophosphamide—Palpitations—Mesalazine—Crohn's disease	0.00107	0.00134	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00106	0.00133	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Azathioprine—Crohn's disease	0.00106	0.00133	CcSEcCtD
Cyclophosphamide—Cough—Mesalazine—Crohn's disease	0.00105	0.00132	CcSEcCtD
Cyclophosphamide—Hypertension—Mesalazine—Crohn's disease	0.00104	0.00131	CcSEcCtD
Cyclophosphamide—Arthralgia—Mesalazine—Crohn's disease	0.00103	0.00129	CcSEcCtD
Cyclophosphamide—Myalgia—Mesalazine—Crohn's disease	0.00103	0.00129	CcSEcCtD
Cyclophosphamide—Chest pain—Mesalazine—Crohn's disease	0.00103	0.00129	CcSEcCtD
Cyclophosphamide—Discomfort—Mesalazine—Crohn's disease	0.00102	0.00127	CcSEcCtD
Cyclophosphamide—Hypotension—Azathioprine—Crohn's disease	0.00101	0.00127	CcSEcCtD
Cyclophosphamide—Cardiac arrest—Prednisone—Crohn's disease	0.00101	0.00126	CcSEcCtD
Cyclophosphamide—Confusional state—Mesalazine—Crohn's disease	0.000994	0.00125	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000986	0.00124	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Mesalazine—Crohn's disease	0.000986	0.00123	CcSEcCtD
Cyclophosphamide—Oedema—Mesalazine—Crohn's disease	0.000986	0.00123	CcSEcCtD
Cyclophosphamide—Infection—Mesalazine—Crohn's disease	0.000979	0.00123	CcSEcCtD
Cyclophosphamide—Shock—Mesalazine—Crohn's disease	0.00097	0.00121	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000965	0.00121	CcSEcCtD
Cyclophosphamide—Tachycardia—Mesalazine—Crohn's disease	0.000962	0.00121	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000953	0.00119	CcSEcCtD
Cyclophosphamide—Anorexia—Mesalazine—Crohn's disease	0.00094	0.00118	CcSEcCtD
Cyclophosphamide—Hypotension—Mesalazine—Crohn's disease	0.000921	0.00115	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000898	0.00112	CcSEcCtD
Cyclophosphamide—Sweating increased—Prednisone—Crohn's disease	0.000893	0.00112	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Azathioprine—Crohn's disease	0.000892	0.00112	CcSEcCtD
Cyclophosphamide—Paraesthesia—Mesalazine—Crohn's disease	0.000885	0.00111	CcSEcCtD
Cyclophosphamide—Dyspnoea—Mesalazine—Crohn's disease	0.000879	0.0011	CcSEcCtD
Cyclophosphamide—Decreased appetite—Mesalazine—Crohn's disease	0.000857	0.00107	CcSEcCtD
Cyclophosphamide—Body temperature increased—Azathioprine—Crohn's disease	0.000855	0.00107	CcSEcCtD
Cyclophosphamide—Fatigue—Mesalazine—Crohn's disease	0.00085	0.00106	CcSEcCtD
Cyclophosphamide—Pain—Mesalazine—Crohn's disease	0.000843	0.00106	CcSEcCtD
Cyclophosphamide—Constipation—Mesalazine—Crohn's disease	0.000843	0.00106	CcSEcCtD
Cyclophosphamide—Weight increased—Prednisone—Crohn's disease	0.000835	0.00105	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Prednisone—Crohn's disease	0.000827	0.00104	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Mesalazine—Crohn's disease	0.000812	0.00102	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Prednisone—Crohn's disease	0.000806	0.00101	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Prednisone—Crohn's disease	0.000802	0.001	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Prednisone—Crohn's disease	0.000802	0.001	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Azathioprine—Crohn's disease	0.000797	0.000999	CcSEcCtD
Cyclophosphamide—Urticaria—Mesalazine—Crohn's disease	0.000783	0.000981	CcSEcCtD
Cyclophosphamide—Body temperature increased—Mesalazine—Crohn's disease	0.000779	0.000976	CcSEcCtD
Cyclophosphamide—Bradycardia—Prednisone—Crohn's disease	0.000747	0.000936	CcSEcCtD
Cyclophosphamide—Diarrhoea—Azathioprine—Crohn's disease	0.00074	0.000927	CcSEcCtD
Cyclophosphamide—Haemoglobin—Prednisone—Crohn's disease	0.000738	0.000924	CcSEcCtD
Cyclophosphamide—Haemorrhage—Prednisone—Crohn's disease	0.000734	0.00092	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Mesalazine—Crohn's disease	0.000726	0.00091	CcSEcCtD
Cyclophosphamide—Dizziness—Azathioprine—Crohn's disease	0.000716	0.000896	CcSEcCtD
Cyclophosphamide—Asthenia—Mesalazine—Crohn's disease	0.000707	0.000886	CcSEcCtD
Cyclophosphamide—Pruritus—Mesalazine—Crohn's disease	0.000697	0.000874	CcSEcCtD
Cyclophosphamide—Vomiting—Azathioprine—Crohn's disease	0.000688	0.000862	CcSEcCtD
Cyclophosphamide—Rash—Azathioprine—Crohn's disease	0.000682	0.000855	CcSEcCtD
Cyclophosphamide—Dermatitis—Azathioprine—Crohn's disease	0.000682	0.000854	CcSEcCtD
Cyclophosphamide—Flushing—Prednisone—Crohn's disease	0.000681	0.000853	CcSEcCtD
Cyclophosphamide—Headache—Azathioprine—Crohn's disease	0.000678	0.000849	CcSEcCtD
Cyclophosphamide—Diarrhoea—Mesalazine—Crohn's disease	0.000674	0.000845	CcSEcCtD
Cyclophosphamide—Arrhythmia—Prednisone—Crohn's disease	0.000656	0.000821	CcSEcCtD
Cyclophosphamide—Dizziness—Mesalazine—Crohn's disease	0.000652	0.000817	CcSEcCtD
Cyclophosphamide—Alopecia—Prednisone—Crohn's disease	0.000649	0.000813	CcSEcCtD
Cyclophosphamide—Nausea—Azathioprine—Crohn's disease	0.000643	0.000805	CcSEcCtD
Cyclophosphamide—Erythema—Prednisone—Crohn's disease	0.000639	0.0008	CcSEcCtD
Cyclophosphamide—Vomiting—Mesalazine—Crohn's disease	0.000627	0.000785	CcSEcCtD
Cyclophosphamide—Rash—Mesalazine—Crohn's disease	0.000621	0.000779	CcSEcCtD
Cyclophosphamide—Dermatitis—Mesalazine—Crohn's disease	0.000621	0.000778	CcSEcCtD
Cyclophosphamide—Headache—Mesalazine—Crohn's disease	0.000617	0.000774	CcSEcCtD
Cyclophosphamide—Vision blurred—Prednisone—Crohn's disease	0.000602	0.000754	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Prednisone—Crohn's disease	0.000593	0.000743	CcSEcCtD
Cyclophosphamide—Anaemia—Prednisone—Crohn's disease	0.000591	0.00074	CcSEcCtD
Cyclophosphamide—Agitation—Prednisone—Crohn's disease	0.000587	0.000736	CcSEcCtD
Cyclophosphamide—Nausea—Mesalazine—Crohn's disease	0.000585	0.000733	CcSEcCtD
Cyclophosphamide—Malaise—Prednisone—Crohn's disease	0.000576	0.000722	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisone—Crohn's disease	0.000554	0.000694	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisone—Crohn's disease	0.000552	0.000691	CcSEcCtD
Cyclophosphamide—Arthralgia—Prednisone—Crohn's disease	0.000544	0.000681	CcSEcCtD
Cyclophosphamide—Myalgia—Prednisone—Crohn's disease	0.000544	0.000681	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisone—Crohn's disease	0.000537	0.000673	CcSEcCtD
Cyclophosphamide—Oedema—Prednisone—Crohn's disease	0.000521	0.000653	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisone—Crohn's disease	0.000521	0.000653	CcSEcCtD
Cyclophosphamide—Infection—Prednisone—Crohn's disease	0.000518	0.000649	CcSEcCtD
Cyclophosphamide—Shock—Prednisone—Crohn's disease	0.000513	0.000643	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisone—Crohn's disease	0.000509	0.000638	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisone—Crohn's disease	0.000504	0.000632	CcSEcCtD
Cyclophosphamide—Anorexia—Prednisone—Crohn's disease	0.000497	0.000623	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000475	0.000595	CcSEcCtD
Cyclophosphamide—Paraesthesia—Prednisone—Crohn's disease	0.000468	0.000587	CcSEcCtD
Cyclophosphamide—Decreased appetite—Prednisone—Crohn's disease	0.000453	0.000568	CcSEcCtD
Cyclophosphamide—Fatigue—Prednisone—Crohn's disease	0.00045	0.000563	CcSEcCtD
Cyclophosphamide—Constipation—Prednisone—Crohn's disease	0.000446	0.000559	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Prednisone—Crohn's disease	0.00043	0.000538	CcSEcCtD
Cyclophosphamide—Urticaria—Prednisone—Crohn's disease	0.000414	0.000519	CcSEcCtD
Cyclophosphamide—Body temperature increased—Prednisone—Crohn's disease	0.000412	0.000516	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Prednisone—Crohn's disease	0.000384	0.000481	CcSEcCtD
Cyclophosphamide—Asthenia—Prednisone—Crohn's disease	0.000374	0.000469	CcSEcCtD
Cyclophosphamide—Pruritus—Prednisone—Crohn's disease	0.000369	0.000462	CcSEcCtD
Cyclophosphamide—Diarrhoea—Prednisone—Crohn's disease	0.000357	0.000447	CcSEcCtD
Cyclophosphamide—Dizziness—Prednisone—Crohn's disease	0.000345	0.000432	CcSEcCtD
Cyclophosphamide—Vomiting—Prednisone—Crohn's disease	0.000332	0.000415	CcSEcCtD
Cyclophosphamide—Rash—Prednisone—Crohn's disease	0.000329	0.000412	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisone—Crohn's disease	0.000329	0.000412	CcSEcCtD
Cyclophosphamide—Headache—Prednisone—Crohn's disease	0.000327	0.000409	CcSEcCtD
Cyclophosphamide—Nausea—Prednisone—Crohn's disease	0.00031	0.000388	CcSEcCtD
